Yasuji Arase Selected Research

Lamivudine (Epivir)

5/2017	Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.
6/2014	Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.
3/2014	Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B.
5/2010	Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients.
4/2010	Clinical and virological effects of long-term (over 5 years) lamivudine therapy.
2/2010	Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants.
2/2010	Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.
3/2009	Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
6/2008	Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.
1/2008	Virological response and hepatocarcinogenesis in lamivudine-resistant hepatitis B virus genotype C patients treated with lamivudine plus adefovir dipivoxil.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuji Arase Research Topics

Disease

80	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2002
51	Chronic Hepatitis C 12/2020 - 01/2002
50	Infections 10/2019 - 01/2002
49	Chronic Hepatitis B 02/2022 - 01/2002
37	Fibrosis (Cirrhosis) 04/2021 - 01/2002
29	Liver Cirrhosis (Hepatic Cirrhosis) 02/2020 - 01/2002
26	Hepatitis 08/2012 - 01/2002
24	Neoplasms (Cancer) 04/2022 - 01/2003
20	Liver Diseases (Liver Disease) 01/2022 - 01/2002
18	Hepatitis B 01/2022 - 01/2002
16	Chronic Hepatitis (Chronic Active Hepatitis) 03/2014 - 01/2003
14	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2009
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2009
11	Carcinogenesis 01/2014 - 01/2003
9	Hepatitis C 11/2015 - 09/2005
8	Diabetes Mellitus 01/2022 - 11/2008
7	Fatty Liver 04/2022 - 09/2009
7	Hypertension (High Blood Pressure) 03/2014 - 09/2009
6	Liver Neoplasms (Liver Cancer) 04/2022 - 12/2010
6	Anemia 10/2014 - 07/2004
5	Insulin Resistance 01/2022 - 06/2009
5	Disease Progression 01/2021 - 01/2004
5	Viremia 01/2017 - 01/2007
4	Virus Diseases (Viral Diseases) 04/2021 - 01/2004
4	Body Weight (Weight, Body) 01/2018 - 10/2007
3	Hyperuricemia 02/2020 - 05/2010
3	Hepatic Encephalopathy 12/2019 - 10/2004
3	Lymphoma (Lymphomas) 12/2019 - 04/2003
3	Chronic Renal Insufficiency 03/2019 - 10/2011
3	Prediabetic State (Prediabetes) 12/2013 - 01/2009
3	Liver Failure 09/2012 - 01/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2012 - 05/2010
2	Esophageal and Gastric Varices (Esophageal Varices) 04/2020 - 12/2019

Drug/Important Bio-Agent (IBA)

69	InterferonsIBA 12/2020 - 01/2002
33	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 01/2002
33	Lamivudine (Epivir)FDA Link 05/2017 - 01/2002
26	Antiviral Agents (Antivirals)IBA 04/2020 - 01/2004
26	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2003
23	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 02/2002
22	Hepatitis B e AntigensIBA 03/2014 - 01/2002
15	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2002
15	Alanine Transaminase (SGPT)IBA 03/2016 - 01/2003
11	entecavir FDA Link 01/2022 - 06/2007
10	AntigensIBA 01/2022 - 01/2002
9	Amino Acids FDA Link 09/2015 - 08/2008
9	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2015 - 01/2006
8	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 07/2011
7	lenvatinibIBA 04/2022 - 01/2020
7	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2020 - 01/2003
7	BilirubinIBA 10/2017 - 01/2003
7	miriplatinIBA 06/2017 - 01/2011
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 08/2008
6	Serum AlbuminIBA 10/2017 - 10/2007
6	adefovir dipivoxil (Hepsera)FDA Link 06/2014 - 01/2004
6	Transaminases (Aminotransferases)IBA 03/2012 - 08/2004
6	Interferon-betaIBA 01/2011 - 01/2008
5	NucleotidesIBA 02/2022 - 09/2004
5	Fetal Proteins (Fetoprotein)IBA 04/2021 - 09/2013
5	lipoarabinomannan (LAM)IBA 05/2017 - 06/2008
5	telaprevirIBA 10/2014 - 01/2010
5	adefovirIBA 06/2014 - 01/2004
5	AlbuminsIBA 07/2013 - 01/2009
5	Interferon-alpha (Interferon Alfa)IBA 12/2010 - 02/2002
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2017
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 01/2010
4	CreatinineIBA 03/2016 - 03/2013
4	Aspartic Acid (Aspartate)FDA Link 04/2010 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 01/2010 - 03/2006
3	Cell-Free Nucleic AcidsIBA 04/2022 - 02/2020
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2017
3	CanagliflozinIBA 01/2022 - 05/2019
3	TransferasesIBA 04/2021 - 08/2004
3	Tenofovir (Viread)FDA Link 04/2021 - 01/2014
3	Ethanol (Ethyl Alcohol)IBA 01/2021 - 03/2013
3	SofosbuvirIBA 01/2018 - 01/2017
3	NucleosidesIBA 05/2017 - 06/2007
3	asunaprevirIBA 01/2017 - 03/2016
3	daclatasvirIBA 01/2017 - 03/2016
3	Dihydrotachysterol (AT 10)IBA 01/2014 - 03/2009
3	PlatinumIBA 03/2013 - 04/2009
3	LDL CholesterolIBA 08/2012 - 05/2010
3	Tyrosine (L-Tyrosine)FDA Link 04/2010 - 05/2004
3	Methionine (L-Methionine)FDA Link 04/2010 - 05/2004
2	Tumor Biomarkers (Tumor Markers)IBA 04/2022 - 01/2008
2	tenofovir alafenamideIBA 02/2022 - 11/2021
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 12/2002
2	Circular DNAIBA 01/2022 - 01/2019
2	Ferritins (Ferritin)IBA 01/2022 - 11/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 08/2020
2	SodiumIBA 04/2021 - 11/2015
2	Biological ProductsIBA 01/2021 - 02/2009
2	wisteria lectinIBA 04/2020 - 01/2019

Therapy/Procedure

132	Therapeutics 04/2022 - 01/2002
15	Radiofrequency Ablation 02/2019 - 01/2002
5	Retreatment 03/2019 - 04/2003
5	Drug Tapering 10/2012 - 07/2004
4	Drug Therapy (Chemotherapy) 09/2013 - 11/2011
3	Aftercare (After-Treatment) 02/2021 - 12/2006
2	Punctures 04/2021 - 11/2014
2	Hepatectomy 10/2020 - 02/2020